Clinical Trials Directory

Trials / Completed

CompletedNCT04612270

Quantification of Clinically Relevant Drug Induced Changes in HbO2 Affinity

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
22 (actual)
Sponsor
Medical University Innsbruck · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Accepted

Summary

The presented study is an experimental in-vitro study without intervention in-vivo. The effects of nitric oxide and prostacyclins, 5-hydroxymethylfurfural and alpha-ketoglutarate, volatile anaesthetics on haemoglobin oxygen (HbO2) affinity will be investigated in-vitro. Venous blood samples of 20 healthy young volunteers (10 female, 10 male) will be collected twice in the period of one week. Informed consent will be given. Every blood collection will be accompanied by a venous blood gas analysis. The blood samples will be transferred to the laboratory for in-vitro recording of the complete oxygen dissociation curve (ODC). A newly developed in-vitro method will be used. On the first study day the blood samples will be exposed to three different concentrations of nitric oxide during the measurement, followed by two different vapourized prostacyclins. In addition, different concentrations of 5-hydroxymethylfurfural and alpha-ketoglutarate will be given to the blood samples for ODC recording. On the second study day the dose dependent effects of three different volatile anaesthetics will be investigated by exposing the blood samples to these drug while the measurements. Following these ODC recordings, aliquots of the blood samples will be frozen and investigated for storage related changes in HbO2 affinity.

Conditions

Interventions

TypeNameDescription
OTHERVenous blood collectionTwo venous blood collections in within one week. No drug-related intervention in-vivo.

Timeline

Start date
2020-11-04
Primary completion
2021-06-01
Completion
2021-06-01
First posted
2020-11-02
Last updated
2021-09-08

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT04612270. Inclusion in this directory is not an endorsement.